Prime Medicine, Inc. financial data

Symbol
PRME on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 515% % -7.6%
Debt-to-equity 167% % 281%
Return On Equity -164% % -42%
Return On Assets -61% % 23%
Operating Margin -3412% % 88%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 180,510,658 shares 38%
Common Stock, Shares, Outstanding 180,309,471 shares 37%
Entity Public Float $296,732,308 USD -51%
Common Stock, Value, Issued $2,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 160,503,183 shares 34%
Weighted Average Number of Shares Outstanding, Diluted 160,503,183 shares 34%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $5,977,000 USD 647%
Research and Development Expense $160,031,000 USD -1.6%
General and Administrative Expense $49,910,000 USD -2%
Operating Income (Loss) $203,964,000 USD 9.9%
Nonoperating Income (Expense) $6,625,000 USD -5.9%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $197,339,000 USD 10%
Earnings Per Share, Basic -1 USD/shares 30%
Earnings Per Share, Diluted -1 USD/shares 30%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $71,396,000 USD -39%
Cash, Cash Equivalents, and Short-term Investments $213,300,000 USD 22%
Other Assets, Current $15,626,000 USD 64%
Assets, Current $231,406,000 USD -6%
Property, Plant and Equipment, Net $22,046,000 USD -5.3%
Operating Lease, Right-of-Use Asset $117,869,000 USD 139%
Other Assets, Noncurrent $0 USD -100%
Assets $385,012,000 USD 16%
Accounts Payable, Current $9,354,000 USD 72%
Employee-related Liabilities, Current $6,759,000 USD -10%
Accrued Liabilities, Current $11,000,000 USD -41%
Contract with Customer, Liability, Current $6,951,000 USD -25%
Liabilities, Current $35,019,000 USD -7.5%
Contract with Customer, Liability, Noncurrent $59,751,000 USD -4.6%
Deferred Income Tax Liabilities, Net $134,000 USD 74%
Operating Lease, Liability, Noncurrent $110,421,000 USD 200%
Liabilities $223,191,000 USD 56%
Accumulated Other Comprehensive Income (Loss), Net of Tax $33,000 USD 57%
Retained Earnings (Accumulated Deficit) $842,275,000 USD -31%
Stockholders' Equity Attributable to Parent $161,821,000 USD -15%
Liabilities and Equity $385,012,000 USD 16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $48,857,000 USD 28%
Net Cash Provided by (Used in) Financing Activities $6,000,000 USD -96%
Net Cash Provided by (Used in) Investing Activities $47,742,000 USD -29%
Common Stock, Shares Authorized 775,000,000 shares 0%
Common Stock, Shares, Issued 180,309,471 shares 37%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $90,599,000 USD -272%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $85,087,000 USD -36%
Deferred Tax Assets, Valuation Allowance $179,777,000 USD 51%
Deferred Tax Assets, Gross $192,629,000 USD 57%
Operating Lease, Liability $118,135,000 USD 186%
Payments to Acquire Property, Plant, and Equipment $2,422,000 USD 4.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $197,327,000 USD 9.9%
Lessee, Operating Lease, Liability, to be Paid $189,706,000 USD -8.8%
Property, Plant and Equipment, Gross $40,603,000 USD 15%
Operating Lease, Liability, Current $7,714,000 USD 72%
Lessee, Operating Lease, Liability, to be Paid, Year Two $22,355,000 USD -4.4%
Lessee, Operating Lease, Liability, to be Paid, Year One $21,703,000 USD 9.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 87%
Deferred Income Tax Expense (Benefit) $0 USD -100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $71,571,000 USD 137%
Lessee, Operating Lease, Liability, to be Paid, Year Three $22,294,000 USD -2.7%
Deferred Tax Assets, Operating Loss Carryforwards $61,501,000 USD 71%
Lessee, Operating Lease, Liability, to be Paid, Year Four $21,478,000 USD -3.7%
Additional Paid in Capital $1,004,061,000 USD 20%
Depreciation, Depletion and Amortization $7,162,000 USD 27%
Share-based Payment Arrangement, Expense $30,694,000 USD 25%